首页> 外文会议>Environment-Enhancing Technology and Material Science International Congress >Comparison of Solvent-Casting and Melt-Compounding Blended Biomedical (Polylactide)-(Polyethylene Glycol) Mixture as Drug Carrier
【24h】

Comparison of Solvent-Casting and Melt-Compounding Blended Biomedical (Polylactide)-(Polyethylene Glycol) Mixture as Drug Carrier

机译:溶剂浇铸和熔融配混的生物医学(聚酰基) - (聚乙二醇)混合物作为药物载体的比较

获取原文
获取外文期刊封面目录资料

摘要

For the purpose of drug carrier and delivery, the polylactide was modified by polyethylene glycol blending with the weight percentage of 80/20 by two methods: solvent-casting and melt-compounding. Characterizations of X-ray diffraction, Scanning Electron Microscope and degradation experiments have been done to study the crystallization, miscibility and degradation behavior. The melt-compounding provides a better miscibility associated with longer degradation time, however the heating procedure effects the polymers. Because of the heating and cooling cycle, the polymers had an opportunity to crystalize and the crystal peak can be seen in the XRD results. While the solvent-casting avoids the high temperature experience of blend with an amorphous state, and provides lower miscibility and short degradation time. These significant features will be considerable factors in drug carrier design.
机译:为了药物载体和递送的目的,通过两种方法的重量百分比的聚乙二醇共混来改变聚酰基转移剂:溶剂浇铸和熔融配合。已经进行了X射线衍射,扫描电子显微镜和降解实验的表征以研究结晶,混溶性和降解行为。熔融复合提供与较长劣化时间相关的更好的混溶性,但是加热过程效果聚合物。由于加热和冷却循环,聚合物具有结晶的机会,并且可以在XRD结果中看到晶体峰。虽然溶剂铸造避免了与非晶态混合的高温经验,并提供较低的混溶性和短降解时间。这些重要特征将是药物载体设计中的相当大的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号